ESC 2021 | TOMAHAWK: Angiography After Resuscitated Patients from Out-Of-Hospital Cardiac Arrest with No ST Elevation.

What triggered this study was a long unanswered question: should patients successfully resuscitated from an out-of-hospital cardiac arrest presenting a non-STEMI ECG be immediately taken to the cath lab? 

ESC 2021 | TOMAHAWK: Angiografía luego de un paro cardíaco reanimado y sin supradesnivel del ST

In response to this question the TOMAHAWK randomized 554 out-of-hospital resuscitated patients without electrocardiographic evidence of ST-segment elevation patients to immediate angiography (n=281) vs intensive care assessment for elective or delayed angiography (n=273).

Finally, for protocol reasons, 265 patients of each arm were analyzed. 

As a first finding, more than half of patients presented a defibrillating rhythm. Both arms required mean 15 minutes between cardiac arrest and return of spontaneous circulation 

Most patients in both arms had coronary lesions in one vessel. 38.1% in the immediate angiography arm vs. 43% in the elective angiography group had a clear culprit lesion. They all received an angiography in both arms. 

At 30 days, observed mortality was 54% in the immediate angiography group vs 46% in the delayed or elective angiography group. This difference was not statistically significative both by protocol analysis and by treatment. 

Most patients in both arms died from cerebral anoxia or circulatory collapse. 


Read also: ESC 2021 | MASTER DAPT: Dual Antiplatelet Therapy After Coronary Angioplasty in Patients at High Bleeding Risk.


There were several secondary end points to look at, though with the same result. Severe neurological deficit resulted similar between the groups, as did all safety end points such as bleeding, stroke or kidney injury. This suggests an early angiography holds neither benefits nor harm. Only when looking at the combination of death and severe neurological deficit do we see a higher incidence in the immediate angiography group (64.3% vs 55.6%, RR 1.16, CI 95% 1 to 1.34). This difference is barely reaching statistical significance. 

Roughly 40% of patients in the TOMAHAWK presented a culprit coronary lesion, but even in these cases, the neurological damage produced during cardiac attest was what sealed patient destiny. 

The outcomes of this study can be classified as neutral, even though its real value lies on patient management at arrival, after resuscitation, and with no ST elevation ECG reading. It seems prudent to take time to rule out other causes of cardiac arrest, count on a lab, etc. 

The TOMAHAWK supports the prior COACT outcomes, which had shown similar results at 90 days and a year.  

TOMAHAWK

Original Title: Angiography after out-of-hospital cardiac arrest without ST-segment elevation.

Reference: Desch S et al. Presentado en el ESC el 29 de agosto 2021 y publicado simultáneamente en NEJM.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...